相关实验视频
Updated: Jul 26, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.7K
KAT5 抑制剂 NU9056 通过c-Myc/miR-202 途径抑制了无塑性甲状腺癌的进展
Wenjing Xu1,2,3, Liwei Xie1,2,3, Yingying Yang1,2,3
1Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
International journal of endocrinology
|June 21, 2023
概括
KAT5抑制剂NU9056通过向KAT5,降低miR-202的调节,并抑制细胞生长来抑制亚塑性甲状腺癌 (ATC). 这突出了KAT5作为攻击性ATC的潜在治疗目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 无塑性甲状腺癌 (ATC) 是一种具有不良预后的侵袭性癌症.
- 升高的氨酸乙转移酶5 (KAT5) 表达与ATC患者的较差结果有关.
研究的目的:
- 研究KAT5抑制剂NU9056在人类ATC细胞中的治疗潜力.
- 阐明NU9056对ATC的影响背后的分子机制.
主要方法:
- 对KAT5表达和患者结果的TCGA数据集的分析.
- 在体外和体内对正常细胞和ATC细胞进行NU9056的研究.
- 微RNA测序,qPCR和双露西法酶记者测定用于识别下游目标.
主要成果:
- NU9056抑制了ATC细胞的存活,生长,迁移,入侵和管形成,同时增强了放射敏感性和化学敏感性.
- 治疗NU9056导致miR-202-5p水平降低,这与c-Myc调节有关.
- 在体内,NU9056通过向KAT5和减少c-Myc半衰期来抑制ATC增殖.
结论:
- NU9056有效地向KAT5,导致c-Myc下调,减少miR-202表达,并抑制ATC.
- 抑制KAT5代表了对形甲状腺癌的有前途的治疗策略.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

